Blume Capital Management’s Sanofi SNY Stock Holding History

Blume Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Sell	47,681 -850	-2%	-$38K	0.3%	67
2026 Q1	$2.34M	Buy	48,531 +22,765	+88%	+$1.06M	0.4%	59
2025 Q4	$1.25M	Buy	25,766 +500	+2%	+$24.8K	0.23%	63
2025 Q3	$1.19M	Buy	25,266 +25,258	+315,725%	+$1.22M	0.23%	62
2025 Q2	$387	Buy	+8	New	+$409	﹤0.01%	390
2024 Q3	–	Sell	-8,710	Closed	-$423K	–	359
2024 Q2	$423K	Hold	8,710	–	–	0.1%	72
2024 Q1	$423K	Buy	+8,710	New	+$425K	0.1%	70
2022 Q4	–	Sell	-200	Closed	-$8K	–	329
2022 Q3	$8K	Hold	200	–	–	﹤0.01%	253
2022 Q2	$10K	Hold	200	–	–	﹤0.01%	246
2022 Q1	$10K	Sell	200 -52,400	-100%	-$2.71M	﹤0.01%	263
2021 Q4	$2.63M	Buy	52,600 +51,600	+5,160%	+$2.55M	0.87%	36
2021 Q3	$48K	Sell	1,000 -500	-33%	-$25.4K	0.02%	174
2021 Q2	$79K	Sell	1,500 -222	-13%	-$11.6K	0.03%	141
2021 Q1	$85K	Buy	+1,722	New	+$82.7K	0.03%	122
2014 Q1	–	Sell	-814	Closed	-$44K	–	263
2013 Q4	$44K	Buy	+814	New	+$42K	0.04%	121

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Blume Capital Management's SNY Position: Q2 2026 in Review

Blume Capital Management reduced its Sanofi (SNY) stake by 1.8% in Q2 2026, selling an estimated $38K and leaving 47,681 shares worth $2.03M. The position accounts for 0.3% of the portfolio, ranked #67.

Blume Capital Management first reported a position in SNY in Q4 2013 and has held it in 15 quarters since. The position peaked at $2.63M in Q4 2021. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Blume Capital Management held 47,681 shares of Sanofi worth $2.03M as of Q2 2026.
Blume Capital Management sold 850 Sanofi shares in Q2 2026, an estimated $38K.
Sanofi made up 0.3% of Blume Capital Management's portfolio in Q2 2026, its #67 holding.
Blume Capital Management first reported a position in Sanofi in Q4 2013 and has held it in 15 quarters since.
Blume Capital Management's Sanofi position peaked at $2.63M in Q4 2021.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.